The wealth of Dr. Mehmet Oz, the celebrity heart surgeon nominated by President Donald Trump to lead the Centers for Medicare and Medicaid ...

Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

The World Ovarian Cancer Coalition (the Coalition) announced today the publication of a first-of-its-kind study that reveals the major socioeconomic burden ovarian cancer has on communities around the ...

The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...

Four more experimental drugs for amyotrophic lateral sclerosis (ALS) have failed to hit the primary endpoint in the phase 2/3 ...

Q2 2025 Earnings Conference Call February 19, 2025 5:00 PM ET. Company Participants. Brad O'Connor - Chief Executive Officer Darren Watson - Chief F ...

During the 1960s, Abbott entered the Japanese market through a joint venture with Dainippon Pharmaceutical Co., Ltd, to manufacture ... The creation of AbbVie In 2011, Abbott announced it was ...

Ovarian cancer continues to pose a significant challenge in the medical field, remaining one of the leading causes of death ...

Principal U.S. Mega-Cap ETF outperformed S&P 500 and peers, benefiting from a strong mega-cap focus and lower volatility.

The iShares Core Dividend Growth ETF (DGRO) holds an affordable and diversified portfolio of U.S. dividend growth stocks.